Cargando…
Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936/ https://www.ncbi.nlm.nih.gov/pubmed/33752851 http://dx.doi.org/10.1016/j.jdmv.2021.01.002 |
_version_ | 1783638534972768256 |
---|---|
author | Lanéelle, D. Dadon, M. Quere, I. Zuily, S. Emmerich, J. Sevestre, M.-A. Mahé, G. |
author_facet | Lanéelle, D. Dadon, M. Quere, I. Zuily, S. Emmerich, J. Sevestre, M.-A. Mahé, G. |
author_sort | Lanéelle, D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7816936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78169362021-01-21 Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France Lanéelle, D. Dadon, M. Quere, I. Zuily, S. Emmerich, J. Sevestre, M.-A. Mahé, G. J Med Vasc Letter to the Editor Elsevier Masson SAS. 2021-04 2021-01-16 /pmc/articles/PMC7816936/ /pubmed/33752851 http://dx.doi.org/10.1016/j.jdmv.2021.01.002 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Lanéelle, D. Dadon, M. Quere, I. Zuily, S. Emmerich, J. Sevestre, M.-A. Mahé, G. Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title | Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title_full | Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title_fullStr | Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title_full_unstemmed | Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title_short | Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France |
title_sort | discontinuation of vascular therapeutics during the covid-19 pandemic first wave in france |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936/ https://www.ncbi.nlm.nih.gov/pubmed/33752851 http://dx.doi.org/10.1016/j.jdmv.2021.01.002 |
work_keys_str_mv | AT laneelled discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT dadonm discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT querei discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT zuilys discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT emmerichj discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT sevestrema discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT maheg discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance AT discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance |